Evidence map›Paper›PMID 42136219›Full record

ArticleMolecular microbiology2026

ISG15 At the Crossroads of Innate Immunity and Host Survival in Response to Typhoid Toxin.

Camila Valenzuela, Jost Enninga

Abstract read
In one paragraph

Article in Molecular microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Camila ValenzuelaCNRS UMR3691, Dynamics of Host-Pathogen Interactions Unit, Institut Pasteur, Université Paris Cité, Paris, France.ORCID 0000-0002-5642-6188
Jost EnningaCNRS UMR3691, Dynamics of Host-Pathogen Interactions Unit, Institut Pasteur, Université Paris Cité, Paris, France.ORCID 0000-0002-5218-349X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Typhoid toxin, a genotoxin secreted by typhoidal Salmonella serovars, has been implicated in diverse host responses ranging from DNA damage to cellular senescence. In this Research Highlight, we discuss how recent findings reveal an unexpected link between toxin-induced DNA damage and a noncanonical interferon-like response centered on ISG15. Using transcriptomic profiling and functional infection models, a recent report by Stark and colleagues shows that intoxicated cells mount a type-I interferon-like transcriptional program independent of interferons. Instead, ISG15 is upregulated via a STING-TBK1-dependent pathway, likely triggered by cytosolic DNA sensing following toxin-induced damage. Strikingly, ISG15 acts independently of its canonical ISGylation activity, remaining in its free form to promote host cell survival and antibacterial defense. Importantly, they demonstrate the role of ISG15 as a key regulator of cellular fate under genotoxic stress. This divergence from canonical interferon signaling does not only add a new flavor to our understanding of the STING pathway, it also points to alternatives for therapeutic intervention that bypass broad interferon activation. By promoting both host cell survival and antimicrobial defenses, this pathway may facilitate persistent infection and intracellular niche formation, revealing a nuanced strategy by which Salmonella exploits host responses to support long-term colonization.

Indexed as

Bacterial ToxinsCytokinesImmunity, InnateUbiquitinsAnimalscGAS-STING Signaling PathwayDNA DamageHost-Pathogen InteractionsHumansInterferon Type IMembrane ProteinsSalmonella typhiSignal TransductionSTING ProteinTyphoid FeverBacterial ToxinsCytokinesInterferon Type IISG15 protein, humanMembrane ProteinsSTING1 protein, humanSTING ProteinUbiquitinsDNA damage responseISG15SalmonellaSTING pathwaytyphoid toxin

Identifiers

PMID42136219
PMCPMC13353737

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.